Role of Atorvastatin for treatment of Central Retinal Vein Occlusion and long term prognosis

Not Applicable

Completed

• Conditions: Central Retinal Vein Occlusion; Eye Diseases; Disorders of choroid and retina

• Registration Number: ISRCTN61985307
• Lead Sponsor: J L Rohatgi Eye Hospital (India)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-07-23
• Last Update Posted: 15 January 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Patients with:
1. Central Retinal Vein Occlusion (CRVO) of more than one day duration
2. No other ophthalmic pathologies
3. No contraindication to atorvastatin
4. No prior use of statins

Exclusion Criteria

Patients with CRVO of less than one day duration are treated conventionally and those who have other ophthalmic pathologies or patients who have been on atorvastatin or any other statins earlier are not included in any groups.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Visual acuity<br>2. Tortuosity of retinal veins

Secondary Outcome Measures

Name	Time	Method
Recurrence of Central Retinal Vein Occlusion